Drug Profile
Cefixime - Lupin
Alternative Names: SupraxLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Lupin Pharmaceuticals
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Chronic bronchitis; Gonorrhoea; Otitis media; Pharyngitis; Tonsillitis; Urinary tract infections
Most Recent Events
- 29 Jan 2019 Launched for Chronic bronchitis in USA (PO)
- 29 Jan 2019 Launched for Gonorrhoea in USA (PO)
- 29 Jan 2019 Launched for Otitis media in USA (PO)